Frédéric Van Gool

3.4k total citations · 1 hit paper
19 papers, 2.2k citations indexed

About

Frédéric Van Gool is a scholar working on Oncology, Immunology and Geriatrics and Gerontology. According to data from OpenAlex, Frédéric Van Gool has authored 19 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 8 papers in Geriatrics and Gerontology. Recurrent topics in Frédéric Van Gool's work include Sirtuins and Resveratrol in Medicine (8 papers), Immune Cell Function and Interaction (8 papers) and PARP inhibition in cancer therapy (8 papers). Frédéric Van Gool is often cited by papers focused on Sirtuins and Resveratrol in Medicine (8 papers), Immune Cell Function and Interaction (8 papers) and PARP inhibition in cancer therapy (8 papers). Frédéric Van Gool collaborates with scholars based in Belgium, United States and Switzerland. Frédéric Van Gool's co-authors include Oberdan Léo, Anthony Rongvaux, Fabienne Andris, Mara Gallí, Jeffrey A. Bluestone, Ari B. Molofsky, Hong-Erh Liang, Richard M. Locksley, Thibaut De Smedt and Jinwoo Lee and has published in prestigious journals such as Nature Medicine, Blood and Immunity.

In The Last Decade

Frédéric Van Gool

19 papers receiving 2.2k citations

Hit Papers

Targeted Elimination of Senescent Beta Cells Prevents Typ... 2019 2026 2021 2023 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
    2019 248 citations Peter J. Thompson, Ajit Shah et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Van Gool Belgium 16 817 620 522 510 484 19 2.2k
Vanessa Byles United States 8 783 1.0× 1.3k 2.1× 237 0.5× 352 0.7× 225 0.5× 10 2.1k
Wei Tang China 27 562 0.7× 1.0k 1.7× 398 0.8× 291 0.6× 81 0.2× 73 2.5k
Beamon Agarwal United States 19 331 0.4× 615 1.0× 333 0.6× 226 0.4× 171 0.4× 43 1.7k
Heng Zeng United States 31 367 0.4× 853 1.4× 113 0.2× 252 0.5× 372 0.8× 64 2.3k
Hyon‐Seung Yi South Korea 31 612 0.7× 1.2k 1.9× 254 0.5× 867 1.7× 87 0.2× 99 3.0k
María I. Vaccaro Argentina 27 283 0.3× 950 1.5× 326 0.6× 1.2k 2.3× 56 0.1× 68 2.3k
Kristen M. Livesey United States 20 762 0.9× 1.6k 2.6× 256 0.5× 1.4k 2.8× 85 0.2× 23 3.3k
Shiqin Xiong United States 19 657 0.8× 1.4k 2.3× 100 0.2× 286 0.6× 148 0.3× 26 2.3k
Yoon‐Jin Lee South Korea 19 124 0.2× 826 1.3× 247 0.5× 247 0.5× 333 0.7× 47 1.7k
Xueyuan Bai China 27 226 0.3× 846 1.4× 112 0.2× 283 0.6× 111 0.2× 77 1.9k

Countries citing papers authored by Frédéric Van Gool

Since Specialization
Citations

This map shows the geographic impact of Frédéric Van Gool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Van Gool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Van Gool more than expected).

Fields of papers citing papers by Frédéric Van Gool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Van Gool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Van Gool. The network helps show where Frédéric Van Gool may publish in the future.

Co-authorship network of co-authors of Frédéric Van Gool

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Van Gool. A scholar is included among the top collaborators of Frédéric Van Gool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Van Gool. Frédéric Van Gool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Müller, Yannick D., Duy Nguyen, Leonardo M. R. Ferreira, et al.. (2021). The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28. Frontiers in Immunology. 12. 639818–639818. 85 indexed citations
2.
Denanglaire, Sébastien, Frédéric Van Gool, Abdulkader Azouz, et al.. (2020). Multiple Environmental Signaling Pathways Control the Differentiation of RORγt-Expressing Regulatory T Cells. Frontiers in Immunology. 10. 3007–3007. 10 indexed citations
3.
Thompson, Peter J., Ajit Shah, Vasilis Ntranos, et al.. (2019). Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metabolism. 29(5). 1045–1060.e10. 248 indexed citations breakdown →
4.
Gool, Frédéric Van, Michelle Nguyen, Maxwell R. Mumbach, et al.. (2019). A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells. Immunity. 50(2). 362–377.e6. 74 indexed citations
5.
Gool, Frédéric Van, et al.. (2019). Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model. PLoS ONE. 14(10). e0217728–e0217728. 24 indexed citations
6.
Wang, David, Kelly M. Mahuron, Chien-Chun Steven Pai, et al.. (2018). Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. Cell Reports. 23(11). 3262–3274. 229 indexed citations
7.
Molofsky, Ari B., Frédéric Van Gool, Hong-Erh Liang, et al.. (2015). Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity. 43(1). 161–174. 347 indexed citations
8.
Kers, Jesper, John Bertin, Peter J. Gough, et al.. (2015). Intracellular nicotinamide adenine dinucleotide promotes TNF-induced necroptosis in a sirtuin-dependent manner. Cell Death and Differentiation. 23(1). 29–40. 36 indexed citations
9.
Gool, Frédéric Van, Ari B. Molofsky, Malika M. Morar, et al.. (2014). Interleukin-5–producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy. Blood. 124(24). 3572–3576. 83 indexed citations
10.
Bondue, Benjamin, Olivier Vosters, Patricia de Nadaı̈, et al.. (2011). ChemR23 Dampens Lung Inflammation and Enhances Anti-viral Immunity in a Mouse Model of Acute Viral Pneumonia. PLoS Pathogens. 7(11). e1002358–e1002358. 82 indexed citations
11.
Gallí, Mara, Frédéric Van Gool, & Oberdan Léo. (2010). Sirtuins and inflammation: Friends or foes?. Biochemical Pharmacology. 81(5). 569–576. 44 indexed citations
12.
Gool, Frédéric Van, Mara Gallí, Cyril Gueydan, et al.. (2009). Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nature Medicine. 15(2). 206–210. 225 indexed citations
13.
Gallí, Mara, Frédéric Van Gool, Anthony Rongvaux, Fabienne Andris, & Oberdan Léo. (2009). The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer. Cancer Research. 70(1). 8–11. 120 indexed citations
14.
Gool, Frédéric Van, Mara Gallí, Anthony Rongvaux, Fabienne Andris, & Oberdan Léo. (2009). Métabolisme du NAD et contrôle de la réponse inflammatoire. médecine/sciences. 25(6-7). 551–553. 1 indexed citations
15.
Busso, Nathalie, Massimo Nobile, Frédéric Van Gool, et al.. (2008). Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD. PLoS ONE. 3(5). e2267–e2267. 206 indexed citations
16.
Rongvaux, Anthony, Mara Gallí, Sébastien Denanglaire, et al.. (2008). Nicotinamide Phosphoribosyl Transferase/Pre-B Cell Colony-Enhancing Factor/Visfatin Is Required for Lymphocyte Development and Cellular Resistance to Genotoxic Stress. The Journal of Immunology. 181(7). 4685–4695. 149 indexed citations
17.
Gool, Frédéric Van, et al.. (2007). Nicotinamide as an anti-inflammatory agent: an in vivo and in vitro study in a mouse model of septic shock. (100.7). The Journal of Immunology. 178(1_Supplement). S198–S198. 1 indexed citations
18.
Gool, Frédéric Van, et al.. (2006). Nicotinamide inhibits B lymphocyte activation by disrupting MAPK signal transduction. Biochemical Pharmacology. 73(6). 831–842. 16 indexed citations
19.
Rongvaux, Anthony, Fabienne Andris, Frédéric Van Gool, & Oberdan Léo. (2003). Reconstructing eukaryotic NAD metabolism. BioEssays. 25(7). 683–690. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanessa Byles Breakdown of academic impact, for papers by Wei Tang Breakdown of academic impact, for papers by Beamon Agarwal Breakdown of academic impact, for papers by Heng Zeng Breakdown of academic impact, for papers by Hyon‐Seung Yi Breakdown of academic impact, for papers by María I. Vaccaro Breakdown of academic impact, for papers by Kristen M. Livesey Breakdown of academic impact, for papers by Shiqin Xiong Breakdown of academic impact, for papers by Yoon‐Jin Lee Breakdown of academic impact, for papers by Xueyuan Bai
Rankless by CCL
2026